Israel - Tiếng Do Thái - Ministry of Health

rekah pharmaceutical industry ltd, israel - neomycin sulfate - טבליה - neomycin sulfate 500 mg - neomycin - neomycin - diarrhea due to enteropathogenic escherichia coli. supression of intestinal bacteria prior to intestinal surgery or as an adjunct in hepatic coma.

Israel - Tiếng Do Thái - Ministry of Health

teva pharmaceutical industries ltd, israel - sulphamethoxazole; trimethoprim - תרחיף - sulphamethoxazole 200 mg / 5 ml; trimethoprim 40 mg / 5 ml - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - treatment of urinary tract infections due to susceptible strains of the following organisms: - escherichia coli - klebsiella - enterobacter - proteus mirabilis - proteus vulgaris - proteus morganii. treatment of acute otitis media in children due to susceptible strains of haemophilus influenzae or streptococcus pneumoniae. to date there are limited data available as to the safety of repeated use of resprim in infants under 2 years of age. resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. treatment of acute exacerbations of chronic bronchitis due to susceptible strains of haemophilus influenzae or streptococcus pneumoniae. treatment of enteritis caused by susceptible strains of shigella flexneri and shigella sonnei. resprim is also indicated in the treatment of documented pneumocystis carinii pneumonitis.

Israel - Tiếng Do Thái - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

Israel - Tiếng Do Thái - Ministry of Health

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

Israel - Tiếng Do Thái - Ministry of Health

comex ltd - ampicillin as trihydrate 250 mg/dose; cloxacillin as benzathine salt 500 mg/dose - suspension - for routine use in cows at drying off, to treat existing intrammammary infections and to assist in preventing new infections occurring during the dry period. it also aids in reducing the incidence of summer mastitis in dry cows and heifers at risk. amongst the organisms found to be sensitive to ampicillin are streptococcus agalactiae, streptococcus spp.,staphylococcus spp, corynebacterium spp and escherichia coli.

Israel - Tiếng Do Thái - Ministry of Health

pfizer pharmaceuticals israel ltd - ceftiofur hydrochloride 50 mg / 1 ml - suspension for injection - infections associated with bacteria sensitive to ceftiofur: in pigs : for the treatment of bacterial respiratory disease associated with pasteurella multocida actinobacillus pleuropneumoniae adn streptococcus suis. in cattle : for the treatment of bacterial respiratory disease associated with mannheimia spp. (pasteurella haemolytica) pasteurella multocida and haemophilus somnus. for the treatment of acute interdigital necrobacillosis ( panaritium foot rot) associated with fusobacterium necrophorum adn bacteroides melaninogenicus (porphyromonas asaccharolytica). for treatment of the bacterial coponent of acute post-partum (puerperal) metritis within 10 days after calving associated with escherichia coli arcanobacterium pyogenes and fusobacteriu necrophorum sensitive to ceftiofur.

Israel - Tiếng Do Thái - Ministry of Health

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 200 mg; clavulanic acid as potassium 50 mg - amoxicillin

Israel - Tiếng Do Thái - Ministry of Health

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 40 mg; clavulanic acid as potassium 10 mg - amoxicillin

Israel - Tiếng Do Thái - Ministry of Health

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 400 mg; clavulanic acid as potassium 100 mg

Israel - Tiếng Do Thái - Ministry of Health

zoetis israel holding b.v., israel - amoxicillin as trihydrate; clavulanic acid as potassium; prednisolone - תמיסה לאינפוזיה - amoxicillin as trihydrate 200 mg/dose; clavulanic acid as potassium 50 mg/dose; prednisolone 10 mg/dose - combinations